abstract |
The present invention relates to a pharmaceutical composition. More particularly, this invention relates to a formulation of a combination composition of growth hormone (GH) and insulin-like growth factor (IGF-1) that provides a stable pharmaceutical composition with the desired ph and without the formation of aggregates. It also relates to a method for producing them. |